Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 4.990
-0.050 (-0.99%)
May 22, 2026, 5:06 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €141.12 million as of May 22, 2026. Its market cap has decreased by -16.00% in one year.
Market Cap
141.12M
Enterprise Value
128.46M
Revenue
8.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.99
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 141.12M, a decrease of -42.33%. That is a compound annual growth rate of -8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 139.72M | -27.05% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.72B |
| argenx SE | 42.60B |
| Financière de Tubize | 8.90B |
| Onward Medical | 191.20M |
| European Medical Solutions | 20.74M |
| Celyad Oncology | 13.20M |
| BioSenic | 1.44M |
| Oxurion NV | 337.03K |